Unilateral radius aplasia due to lamotrigine and oxcarbazepine use in pregnancy

References

• Morrell M J. The new antiepileptic drugs and women: efficacy, reproductive health, pregnancy and fetal outcome. Epilepsia 1996; 37: 34–44
   PubMed Web of Science ®Google Scholar
• Lindhout D, Meinardi H, Meijer J WA, Nau H. Antiepileptic drugs and teratogenesis in two consecutive cohorts. Neurology 1992; 42: 94–110
   PubMedGoogle Scholar
• Sabers A, aRogvı-Hansen B, Dam M, Fischer-Rasmussen W, Gram L, Hansen M, Moller A, Winkel H. Pregnancy and epilepsia: a retrospective study of 151 pregnancies. Acta Neuro Scand 1998; 97: 164–170
   PubMedGoogle Scholar
• Arpino C, Brescıanını S, Robert E, Castilla E E, Cocchi C, Cornel M C, de Vigan C, Lancaster P A, Merlob P, Sumiyoshi Y, et al. Teratogenic effects of antiepileptic drugs: use of an international database on malformations and drug exposure (MADRE). Epilepsia 2000; 41: 1436–1443
   PubMed Web of Science ®Google Scholar
• Sabers A, Dam M, A-Rogvi-Hansen B, Boas J, Sidenius P, Laue F M, Alving J, Dahl M, Ankerhus J, Mouritzen Dam A. Epilepsy and pregnancy: lamotrigine as main drug used. Acta Neurol Scand 2004; 109: 9–13
   PubMed Web of Science ®Google Scholar
• Holmes L B, Harvey B A, Coull K B, Huntington K B, Khoshbin S, Hayes A M, Ryan L M. The teratogenicity of anticonvulsant drugs. N Engl J Med 2001; 344: 1132–1138
   PubMed Web of Science ®Google Scholar
• Tierny L M, Jr, McPhee S J, Papadakis M A. Current medical diagnosis and treatment45th edn. Lange Medical Books/McGraw-Hill, New York 2006
   Google Scholar
• Tennis P, Eldridge R R, and the International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Preliminary results on pregnancy outcomes in women using lamotrigine. Epilepsia 2002; 43: 1161–1167
   PubMed Web of Science ®Google Scholar
• Meischenguiser R, D'Giano C H, Ferraro S M. Oxcarbazepine in pregnancy: clinical experience in Argentina. Epilepsy Behav 2004; 5: 163–167
   PubMed Web of Science ®Google Scholar
• Tatum W O, Liporace J, Benbadis S R, Kaplan P W. Updates on the treatment of epilepsy in women. Arch Intern Med 2004; 164: 137–145
   PubMed Web of Science ®Google Scholar
• McElhatton P. Teratogenic drugs – part 1. Adverse Drug React Bull 2002; 213: 815–818
   Google Scholar
• Wong I C, Mawer G E, Sander J W. Adverse event monitoring in lamotrigine patients: a pharmacoepidemiologic study in the United Kingdom. Epilepsia 2001; 42: 237–244
   PubMed Web of Science ®Google Scholar
• Ohman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate and during lactation. Epilepsia 2000; 41: 709–713
   PubMed Web of Science ®Google Scholar
• Richens A. Safety of lamotrigine. Epilepsia 1994; 35: 37–40
   PubMed Web of Science ®Google Scholar
• Vajda F J, Hitchcock A, Graham J, Solinas C, O'Brien T J, Lander C M, Eadie M J. Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry. Eur J Neurol 2006; 13: 645–654
   PubMed Web of Science ®Google Scholar
• Ornoy A. Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy. Reprod Toxicol 2006; 22: 214–226
   PubMed Web of Science ®Google Scholar
• Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, Irwin B, McGivem R C, Morrison P J, Craig J. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Registery. J Neurol Neurosurg Psychiatry 2006; 77: 193–198
   PubMed Web of Science ®Google Scholar
• Tatum W O. Use of antiepileptic drugs in pregnancy. Expert Rev Neurother 2006; 6: 1077–1086
   PubMedGoogle Scholar
• Prakash, Prabhu L V, Nasar M A, Rai R, Madhyastha S, Singh G. Singapore Med J 2007; 48: 880–883
   PubMedGoogle Scholar
• Montouris G. Safety of the newer antiepileptic drug oxcarbazepine during pregnancy. Curr Med Res Opin 2005; 21: 693–701
   PubMed Web of Science ®Google Scholar
• Samren E B, van Duijn C M, Christianes G C, Hofman A, Lindhout D. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 1999; 46: 739–746
   PubMed Web of Science ®Google Scholar
• Gentile S. Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers. Bipolar Disord 2006; 8: 207–220
   PubMed Web of Science ®Google Scholar
• Bilic S, Steinhoff B J. Schwangerschaftsverlauf bei prognostisch ungunstiger Gesamtkonstellation. Z Epileptol 2004; 17: 165
   Google Scholar
• Clayton-Smith J, Donnai D. Fetal valproate syndrome. J Med Genet 1995; 32: 724–727
   PubMed Web of Science ®Google Scholar
• Cunnington M, Ferber S, Quartey G. Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study. Epilepsia 2007; 48: 1207–1210
   PubMed Web of Science ®Google Scholar